Taiwan FDA registration 72c0a43b1513c12fa98920f0563d888d

Figure: Hepatitis C antibody rapid screening

TW: 圖優C型肝炎抗體快篩

Taiwan·Risk Class 3·TURKAB MEDICAL MLZ. SAN. VE TIC.A.S. PRODUCTION BRANCH·Registered Jul 13, 2022 – Jul 13, 2027Active

Registration details

Analysis ID: 72c0a43b1513c12fa98920f0563d888d
Customs Code: DHA05603567400

Company information

Manufacturer: TURKAB MEDICAL MLZ. SAN. VE TIC.A.S. PRODUCTION BRANCH
Manufacturer Country: Türkiye
Authorized Representative: HONG CHI BIOTECH CO., LTD.

Product details

Intended Use: This product uses chromatographic immunoassay to qualitatively detect HCV antibodies in human whole blood/serum/plasma.
Product Type (Level 1): B Hematology, pathology, and genetics
Product Type (Level 2): B.4020 Analysis of specific tests
Import Information: Input;; QMS/QSD

Dates and status

Registration Date: Jul 13, 2022
Expiry Date: Jul 13, 2027

About this record

Access comprehensive regulatory information for Figure: Hepatitis C antibody rapid screening in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 3 medical device is registered under number 72c0a43b1513c12fa98920f0563d888d and manufactured by TURKAB MEDICAL MLZ. SAN. VE TIC.A.S. PRODUCTION BRANCH. The authorized representative in Taiwan is HONG CHI BIOTECH CO., LTD..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.